189 related articles for article (PubMed ID: 33537947)
21. International patterns of dual antiplatelet therapy duration after acute coronary syndromes.
Bueno H; Pocock S; Danchin N; Annemans L; Gregson J; Medina J; Van de Werf F
Heart; 2017 Jan; 103(2):132-138. PubMed ID: 27504002
[TBL] [Abstract][Full Text] [Related]
22. The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project.
Yang L; Ye N; Wang G; Bian W; Xu F; Zhao D; Liu J; Hao Y; Liu J; Yang N; Cheng H;
BMC Cardiovasc Disord; 2021 Jul; 21(1):345. PubMed ID: 34273963
[TBL] [Abstract][Full Text] [Related]
23. Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease.
Carrero JJ; Varenhorst C; Jensevik K; Szummer K; Lagerqvist B; Evans M; Spaak J; Held C; James S; Jernberg T
Kidney Int; 2017 Jan; 91(1):216-226. PubMed ID: 27865441
[TBL] [Abstract][Full Text] [Related]
24. Contemporary inter-hospital transfer patterns for the management of acute coronary syndrome patients: findings from the EPICOR study.
Sinnaeve PR; Zeymer U; Bueno H; Danchin N; Medina J; Sánchez-Covisa J; Licour M; Annemans L; Jukema JW; Pocock S; Storey RF; Van de Werf F
Eur Heart J Acute Cardiovasc Care; 2015 Jun; 4(3):254-62. PubMed ID: 25210075
[TBL] [Abstract][Full Text] [Related]
25. Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: Insights from EPICOR, an international study of current practice patterns.
Bueno H; Sinnaeve P; Annemans L; Danchin N; Licour M; Medina J; Pocock S; Sánchez-Covisa J; Storey RF; Jukema JW; Zeymer U; Van de Werf F;
Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):3-12. PubMed ID: 25561688
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and outcomes of medically managed patients with non-ST-segment elevation acute coronary syndromes: Insights from the multinational EPICOR Asia study.
Chin CT; Ong TK; Krittayaphong R; Lee SW; Sawhney JPS; Kim HS; Garcia AA; Bueno H; Pocock SJ; Nhan VT; Vega A; Hayashi N; Huo Y
Int J Cardiol; 2017 Sep; 243():15-20. PubMed ID: 28747021
[TBL] [Abstract][Full Text] [Related]
27. Impact of statin therapy on renal function and long-term prognosis in acute coronary syndrome patients with chronic kidney disease.
Shibui T; Nakagomi A; Kusama Y; Atarashi H; Mizuno K
Int Heart J; 2010; 51(5):312-8. PubMed ID: 20966602
[TBL] [Abstract][Full Text] [Related]
28. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH;
Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056
[TBL] [Abstract][Full Text] [Related]
29. Guideline-adherent therapy in patients with acute coronary syndromes. The EPICOR registry in Germany.
Zeymer U; Heuer H; Schwimmbeck P; Genth-Zotz S; Wolff K; Nienaber CA;
Herz; 2015 Mar; 40 Suppl 1():27-35. PubMed ID: 25374386
[TBL] [Abstract][Full Text] [Related]
30. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.
Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C
BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244
[TBL] [Abstract][Full Text] [Related]
31. Disparities in the Estimation of Glomerular Filtration Rate According to Cockcroft-Gault, Modification of Diet in Renal Disease-4, and Chronic Kidney Disease Epidemiology Collaboration Equations and Relation With Outcomes in Patients With Acute Coronary Syndrome.
Rivera-Caravaca JM; Ruiz-Nodar JM; Tello-Montoliu A; Esteve-Pastor MA; Quintana-Giner M; Véliz-Martínez A; Orenes-Piñero E; Romero-Aniorte AI; Vicente-Ibarra N; Pernias-Escrig V; Carrillo-Alemán L; Candela-Sánchez E; Hortelano I; Villamía B; Sandín-Rollán M; Nuñez-Martínez L; Valdés M; Marín F
J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29680822
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a novel score for predicting 2-year outcomes in patients with acute coronary syndrome after percutaneous coronary intervention.
Liu Y; Yao Y; Tang XF; Xu N; Jiang P; Jiang L; Zhao XY; Chen J; Yang YJ; Gao RL; Xu B; Yuan JQ
J Chin Med Assoc; 2019 Aug; 82(8):616-622. PubMed ID: 31135575
[TBL] [Abstract][Full Text] [Related]
33. Chronic kidney disease is associated with adverse outcomes among elderly patients taking clopidogrel after hospitalization for acute coronary syndrome.
Fischer MJ; Ho PM; McDermott K; Lowy E; Parikh CR
BMC Nephrol; 2013 May; 14():107. PubMed ID: 23688069
[TBL] [Abstract][Full Text] [Related]
34. The dose-response association between estimated glomerular filtration rate and prognosis of patients with ST-segment elevation myocardial infarction from rural areas of China's Liaoning province.
Li G; Qi G; Zhang B; Zhou B; Ma B; Jiang D; He Q; Ai C; Dai H; Li Y; Shi J
Medicine (Baltimore); 2017 Dec; 96(52):e9508. PubMed ID: 29384954
[TBL] [Abstract][Full Text] [Related]
35. Predictors of all-cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry.
Rossello X; Bueno H; Pocock SJ; Van de Werf F; Danchin N; Annemans L; Medina J; Zeymer U
Clin Cardiol; 2019 Jan; 42(1):111-119. PubMed ID: 30443916
[TBL] [Abstract][Full Text] [Related]
36. [Renal insufficiency and clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a multi-centre study].
Huo Y; Ho W
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 39(6):624-9. PubMed ID: 18087555
[TBL] [Abstract][Full Text] [Related]
37. P2Y
Bonello L; Angiolillo DJ; Aradi D; Sibbing D
Circulation; 2018 Oct; 138(15):1582-1596. PubMed ID: 30354508
[TBL] [Abstract][Full Text] [Related]
38. Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.
Baber U; Chandrasekhar J; Sartori S; Aquino M; Kini AS; Kapadia S; Weintraub W; Muhlestein JB; Vogel B; Faggioni M; Farhan S; Weiss S; Strauss C; Toma C; DeFranco A; Baker BA; Keller S; Effron MB; Henry TD; Rao S; Pocock S; Dangas G; Mehran R
JACC Cardiovasc Interv; 2017 Oct; 10(20):2017-2025. PubMed ID: 28780028
[TBL] [Abstract][Full Text] [Related]
39. A retrospective study on the risk factors for bleeding events in warfarin therapy, focusing on renal function.
Hirai T; Hamada Y; Geka Y; Kuwana S; Hirai K; Ishibashi M; Fukaya Y; Kimura T
Eur J Clin Pharmacol; 2017 Nov; 73(11):1491-1497. PubMed ID: 28795244
[TBL] [Abstract][Full Text] [Related]
40. Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).
Goicoechea M; de Vinuesa SG; Quiroga B; Verde E; Bernis C; Morales E; Fernández-Juárez G; de Sequera P; Verdalles U; Delgado R; Torres A; Arroyo D; Abad S; Ortiz A; Luño J
Cardiovasc Drugs Ther; 2018 Jun; 32(3):255-263. PubMed ID: 29943364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
